PCT

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of PureCycle Technologies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2023 – (NASDAQ: PCT)

Retrieved on: 
Wednesday, November 22, 2023
NEXT, Fraud, Risk, PCT, Security (finance)

DEADLINE: November 28, 2023 Shareholders should not delay in registering for this class action.

Key Points: 
  • DEADLINE: November 28, 2023 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is November 28, 2023.
  • The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of PureCycle Technologies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2023 – (NASDAQ: PCT)

Retrieved on: 
Monday, November 13, 2023
Risk, NEXT, Fraud, PCT, Holding company, Security (finance)

DEADLINE: November 28, 2023 Shareholders should not delay in registering for this class action.

Key Points: 
  • DEADLINE: November 28, 2023 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is November 28, 2023.
  • The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

PURECYCLE STOCK ALERT: Don't Miss the Lead Plaintiff Deadline in the PCT Class Action, Contact Robbins LLP Today

Retrieved on: 
Friday, November 10, 2023
Inform, SAN, LLP, Complaint, Procter & Gamble, PCT, Person, News, Security (finance), Inc.

For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.

Key Points: 
  • For more information, submit a form , email Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • On September 13, 2023, PureCycle disclosed that its Ironton Facility experienced a full plant power outage on August 7, 2023, which required the facility to halt operations.
  • What Now: Similarly situated shareholders may be eligible to participate in the class action against PureCycle Technologies, Inc. Shareholders who want to act as lead plaintiff for the class must file their motion for lead plaintiff by November 28, 2023.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform

Retrieved on: 
Wednesday, December 13, 2023
Oncology, Health, Medical Devices, Genetics, Clinical Trials, Pharmaceutical, Biotechnology, Patent Cooperation Treaty, Artery, SBRT, Potyvirus, Data monitoring committee, DMC, PCT, FDA, LAPC, Standard of care, Patent, Vein, TAMP, Pharmaceutical industry

RenovoRx, Inc. (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced today that the Company has filed an international patent application under the Patent Cooperation Treaty (PCT) for its novel Trans-Arterial Micro-Perfusion (TAMP) therapy platform.

Key Points: 
  • RenovoRx, Inc. (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced today that the Company has filed an international patent application under the Patent Cooperation Treaty (PCT) for its novel Trans-Arterial Micro-Perfusion (TAMP) therapy platform.
  • The patent portfolio covers two main areas, mechanical and biological.
  • RenovoRx believes that these methods and apparatuses via the TAMP therapy platform may provide a novel and important pathway for the targeted delivery of therapeutic classes across DNA/RNA-altering modalities, cell therapy, oncolytic viruses, bi-specific antibodies, and monoclonal antibodies for the treatment of a variety of clinical indications.
  • "This patent application further expands the value of TAMP into the delivery of larger therapeutic assets, as a unique platform in oncology, beyond our current Phase III clinical asset," said Shaun Bagai, CEO, RenovoRx.

Patsnap Releases the 2023 Global Innovation Report

Retrieved on: 
Thursday, November 16, 2023
Telecommunications, Biomedical engineering, Organization, PCT, GTM, Intellectual property, Marketing, Toshiba, Health care, Patent, Creative industries, Renewable energy, Pharmaceutical industry, Fine chemical, Atom, Honeywell

LONDON, Nov. 16, 2023 /PRNewswire/ -- Patsnap, the global leader in innovation and intellectual property intelligence, today revealed its highly anticipated "2023 Global Innovation Report" including this year's "Global Innovation 100" and "Global Disruption 50" lists.

Key Points: 
  • LONDON, Nov. 16, 2023 /PRNewswire/ -- Patsnap, the global leader in innovation and intellectual property intelligence, today revealed its highly anticipated "2023 Global Innovation Report" including this year's "Global Innovation 100" and "Global Disruption 50" lists.
  • "The abundant tech data behind the Global Innovation 100 and Global Disruption 50 also sheds light on the overall landscape of innovation", said Haydn Evans, Senior Director of Marketing and GTM of Patsnap, "We can clearly see that innovation is deeply interconnected.
  • 99 out of the Global Innovation 100 participants have collaborated on technology innovation with others from the list.
  • The Global Innovation Report is built using Patsnap's proprietary Company Innovation Capability Evaluation Model.

Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability

Retrieved on: 
Friday, November 10, 2023
Patent Cooperation Treaty, Social, Climate change, Employment, Disability, PCR, PCT, Corporate governance, KCGS, Sustainability studies, Information, Transport, ESG

SEOUL, South Korea, Nov. 10, 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced on November 10 that it has received an overall rating of 'B+' in the 2023 ESG evaluation conducted by the Korea Institute of Corporate Governance and Sustainability (KCGS).

Key Points: 
  • KCGS, one of the major ESG evaluation agencies in South Korea, annually rates the level of sustainable management, in the categories of environmental, social and governance, of domestically listed companies.
  • Specifically, the company improved one level in the environmental category (from 'B' to 'B+'), maintained a 'B+' in the social category and improved three levels in the governance category (from 'D' to 'B+').
  • Seegene strengthened the 'Social' category by announcing its Human Rights Management Declaration and establishing an Information Security Management System.
  • Regarding 'Governance,' the ESG Committee was formed to oversee internal/external key ESG issues and risks.

Capital Markets Day 2023

Retrieved on: 
Wednesday, December 13, 2023
Plasma, Growth, PCT, Digitalization, ROCE, IXS, CHF, Comet, IXM, EBITDA, CET, Heart, Semiconductor, Capital market, Electronics

This provides Comet with a leading position in these markets and numerous catalysts that boost growth.

Key Points: 
  • This provides Comet with a leading position in these markets and numerous catalysts that boost growth.
  • Like PCT, the two x-ray divisions X-Ray Systems (IXS) and X-Ray Modules (IXM) have made significant progress in their realignment towards growth and future markets.
  • IXM has successfully placed its technologically leading x-ray tubes and modules in the target markets of semiconductors, electronics, and batteries.
  • Comet will hold a Capital Markets Day in the form of an in-person event on November 9, 2023, from 9:30 am to 12:15 pm CET at the Hotel Widder in Zurich, Switzerland.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of PureCycle Technologies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2023 – (NASDAQ: PCT)

Retrieved on: 
Wednesday, November 8, 2023
NEXT, PCT, Inc., Fraud, Risk, Holding company, Security (finance)

DEADLINE: November 28, 2023 Shareholders should not delay in registering for this class action.

Key Points: 
  • DEADLINE: November 28, 2023 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is November 28, 2023.
  • The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of PureCycle Technologies, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 28, 2023 - (NASDAQ: PCT)

Retrieved on: 
Tuesday, November 7, 2023
NEXT, PCT, Fraud, Risk, Holding company, Security (finance)

DEADLINE: November 28, 2023 Shareholders should not delay in registering for this class action.

Key Points: 
  • DEADLINE: November 28, 2023 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is November 28, 2023.
  • The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

First Mover of Global Trade Index Based On Biome Molecule, Kwanyoung Park of AndKwan Natural Science

Retrieved on: 
Tuesday, November 7, 2023
Intelligence, Patent, Carbon, Organic, Multimedia, Environment, PCT, Transport, Marketing, Plant, Algorithm, Natural Resources, Plastic, Deep learning, Semiconductor, Clothing, Cryptocurrency, Online shopping, Pharmaceutical industry

It is an integrated system that is digitized and managed through deep learning algorithms.

Key Points: 
  • It is an integrated system that is digitized and managed through deep learning algorithms.
  • After creating this hypothesis in 2010, CEO Park went to the UK as a metropolitan country with a multinational population, aiming to refine the theory.
  • In 2015, Park set China as the first target country to test her hypothesis.
  • This is because China had the most active manufacturing orders and trade in almost every industry in the world.